All Environmental risk assessment articles
-
JournalFrom laboratory to patient: The role of New Substance Notifications in delivering innovative therapies in Canada
This article explores the new substance notification (NSN) processes and provides guidance on navigating this.
-
JournalEnvironmental impact of pharmaceuticals and regulation in the EU
The profound impact of pharmaceuticals on the environment has been acknowledged for decades. In the EU, two key mechanisms that assess this risk are the Environmental Risk Assessment (ERA), and Registration, Evaluation, Authorisation and Restriction of Chemicals (REACH). As both frameworks are under assessment, this article looks at the key considerations within the ERA.